Micheal Avoseh: Exploring Nanoparticle-Based Therapies for Thrombosis and Vascular Inflammation
Micheal Avoseh, Doctoral Researcher at University of South Carolina Floyd School of Medicine, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in blood VTH, adding:
“I’m excited to share that our article, Endothelium-Targeted and Untargeted Nanoparticle Therapies in Thrombo-Inflammatory Vascular Diseases, is now published in blood VTH.
This review explores how nanoparticle-based therapies may help address thrombo-inflammatory vascular disease, including approaches that target the endothelium—the inner lining of blood vessels—and approaches that do not.
It was a valuable opportunity to examine how drug delivery strategies could improve the way we approach complex vascular inflammation and thrombosis.
I’m grateful to my co-authors and mentors for their collaboration and guidance throughout this work.”
Title: Endothelium-Targeted and Untargeted Nanoparticle Therapies in Thrombo-Inflammatory Vascular Diseases
Authors: Micheal O. Avoseh, Hua Jin, Oscar Moreno, Andrea T. Obi, Peter K. Henke, Souvik Sen, Michael A. Matthay, You-Yang Zhao, Colin E. Evans

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning